Early research (Phase 1)Study completedNCT00025415
What this trial is testing
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60